• GLP-1 (9-36) Amide: Mechanistic Insights for Precision Metab

  2026-05-22

  Discover advanced mechanistic insights into GLP-1 (9-36) amide, a leading glucagon-like peptide-1 receptor antagonist. This article uniquely explores high-throughput assay strategies and receptor cross-talk, equipping metabolic researchers with actionable guidance.

• GLP-1 (9-36) amide: Precision Antagonism in Metabolic Resear

  2026-05-22

  GLP-1 (9-36) amide enables high-fidelity dissection of GLP-1 receptor signaling, offering researchers a rigorously validated tool for metabolic and type 2 diabetes studies. By leveraging its selectivity and handling precision, scientists can achieve reproducible results where clarity of receptor pathway interrogation is paramount.

• Deracoxib and Piroxicam Cytotoxicity in Canine Osteosarcoma

  2026-05-21

  This study examines the in vitro effects of deracoxib and piroxicam on the viability of canine osteosarcoma cell lines, revealing that deracoxib is a more potent inhibitor of tumor cell growth than piroxicam at high concentrations. The findings inform ongoing efforts to identify adjunctive therapies that selectively target osteosarcoma cells without affecting healthy fibroblasts.

• Nonconventional Agonist-Antagonist Interplay at the GLP-1 Re

  2026-05-21

  This study uncovers unexpected cross-reactivity and novel signaling behaviors between glucagon, GLP-1, and their respective receptor modulators, challenging the traditional paradigm of strict GPCR selectivity. Using high-throughput FRET assays, the authors reveal that glucagon can serve as a nonconventional agonist at the GLP-1 receptor, with significant implications for interpreting metabolic and diabetes research.

• Parathyroid hormone (1-34) (human): Mechanism & Research Uti

  2026-05-20

  Parathyroid hormone (1-34) (human) is a bioactive peptide that selectively activates parathyroid hormone receptors, enabling precise dissection of calcium and bone metabolism in experimental models. Its potency and solubility profile support advanced research on osteoporosis and kidney disease. The A1129 kit from APExBIO is validated for high-fidelity receptor signaling studies.

• 2-Deoxy-D-glucose: Precision Control of Tumor Metabolism in

  2026-05-20

  Explore how 2-Deoxy-D-glucose (2-DG) enables advanced, targeted metabolic modulation in cancer research. This article offers a unique, assay-driven perspective on glycolysis inhibition and practical workflow decisions for researchers.

• InstaBlue Protein Stain Solution for Rapid Gel Visualization

  2026-05-19

  InstaBlue Protein Stain Solution addresses the need for fast, sensitive protein visualization directly in polyacrylamide gels, streamlining workflows by eliminating fixation and destaining. This reagent is ideal for protein electrophoresis analysis requiring mass spectrometry compatibility and minimal protein modification, but is not suited where solvent-based staining or post-staining gel processing is required.

• Anti Reverse Cap Analog: Optimizing Synthetic mRNA Translati

  2026-05-19

  Anti Reverse Cap Analog (ARCA), 3´-O-Me-m7G(5')ppp(5')G revolutionizes in vitro mRNA capping by ensuring correct orientation and boosting translation efficiency. Discover how ARCA, supplied by APExBIO, transforms mRNA therapeutics research workflows with superior yield, stability, and reproducibility.

• Parathyroid hormone (1-34) (human): Optimizing Bone & Kidney

  2026-05-18

  Parathyroid hormone (1-34) (human) stands at the forefront of translational bone and kidney research, enabling precise control of PTH/PTHrP receptor signaling for robust disease modeling. With its high biological activity and APExBIO’s trusted quality, this peptide fragment streamlines workflows in both classical osteoporosis assays and cutting-edge kidney assembloid systems.

• BIBP 3226 trifluoroacetate: Optimizing NPY/NPFF System Resea

  2026-05-18

  BIBP 3226 trifluoroacetate stands out as a potent, selective tool for dissecting the roles of neuropeptide Y Y1 and NPFF receptors in cardiovascular, anxiety, and analgesia research. This article translates recent advances in adipose-neural axis modeling into actionable protocols, troubleshooting strategies, and comparative insights for maximizing experimental success.

• HOBt in Peptide Synthesis: Driving Translational Advances

  2026-05-17

  Explore how HOBt (1-Hydroxybenzotriazole) empowers translational researchers to achieve high-fidelity peptide synthesis, minimize epimerization, and accelerate drug discovery—spotlighting mechanistic insights, protocol parameters, and real-world impacts from glucagon receptor antagonist development.

• Indazole/Indole Glucagon Receptor Antagonists: Synthesis & S

  2026-05-16

  This study introduces a novel series of indazole- and indole-based glucagon receptor antagonists for type 2 diabetes, detailing their synthesis, structure–activity relationships, and in vivo efficacy. The work emphasizes the importance of advanced amide bond formation strategies for generating potent molecules with optimal pharmacological profiles.

• Adipose-Neural Axis in Epicardial Fat Drives Cardiac Arrhyth

  2026-05-15

  Fan et al. (2024) demonstrate that adipocyte-neural interactions, particularly via leptin and the neuropeptide Y/Y1 receptor axis, play a direct role in the development of epicardial adipose tissue (EAT)-related cardiac arrhythmias. Their stem cell-based coculture model provides mechanistic insights and highlights new molecular targets for arrhythmia intervention.

• Brefeldin A in Cancer and ER Stress Research: Workflows & In

  2026-05-15

  Brefeldin A (BFA) stands out as a robust, mechanistically precise ATPase and vesicle transport inhibitor for dissecting ER stress and apoptosis pathways in cancer and endothelial cells. This guide demystifies BFA's experimental workflows, showcases troubleshooting strategies, and ties in recent evidence on cytoskeletal biomarkers from sepsis research to enhance assay rigor.

• Vincristine Sulfate in Cancer Research: Optimized Workflows

  2026-05-14

  Vincristine sulfate empowers cancer researchers to dissect microtubule dynamics and drive reproducible antitumor assays. This article delivers workflow-enhancing protocols, troubleshooting strategies, and evidence-backed use-cases, positioning APExBIO’s Vincristine sulfate as the trusted reagent for high-impact oncology studies.

16194 records 1/1080 page Next 12345 下5页 Last page